According to the ClinicalTrials.gov database, nearly 100 studies have targeted TRPV1 for various conditions, with a focus on asthma and cough, inflammatory skin diseases, and, in particular, various pain conditions. The gene discussed is TRPV1; the disease is inflammatory skin disease.